发明名称 |
COPOLYMERS FOR SUPPRESSION OF AUTOIMMUNE DISEASES, AND METHODS OF USE |
摘要 |
Random three- and four-amino acid copolymers having lengths of 14-,35- and 5 0- amino acid residues are provided. Fifty-mers of FEAK were effective inhibito rs of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones. These copolymers efficiently suppressed EAE induced in susceptible SJL/J (H-2s) strain of mice with either whole spinal cord homogenate (WSCH) or with the encephalitogenic epitope PLP 139-151. YFAK 50- mer having a molar ratio of about y 0.8:F 0.2 inhibited binding of biotinylated MBP 85-99 epitope to HLA-DR-2 molecules more efficiently than either unlabeled MBP 85-99 or Copaxone.RTM.. YFAK and FAK copolymers efficiently suppressed EAE induced in SJL/J (H-2s) mice with the encephalitogenic epitope PLP 139-151. Copolymers YFK, VYAK and tryptophan- containing VWAK were efficacious in alleviating severity and duration of symptoms of EAE induced by MBP 85-99, in a humanized mouse model expressing genes for both an HLA-DR-2 linked to multiple sclerosis (MS) in humans and f or a T cell receptor from an MS patient. |
申请公布号 |
CA2462459(A1) |
申请公布日期 |
2003.04.10 |
申请号 |
CA20022462459 |
申请日期 |
2002.10.03 |
申请人 |
PRESIDENT AND FELLOWS OF HARWARD COLLEGE |
发明人 |
FRIDKIS-HARELI, MASHA;STROMINGER, JACK L. |
分类号 |
A61K45/00;A61K38/00;A61K38/20;A61K38/21;A61K38/55;A61P3/10;A61P5/14;A61P7/04;A61P17/06;A61P21/04;A61P25/00;A61P29/00;A61P31/04;A61P37/02;A61P43/00;C07K14/00;(IPC1-7):A61K38/00;A61K39/00;C08H1/00;A61P37/00;C07K5/10;A61K38/16 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|